<DOC>
	<DOCNO>NCT00608296</DOCNO>
	<brief_summary>The purpose research study brain structure , function chemistry patient bipolar disorder receive quetiapine lithium , order well understand benefit treatment respond medication .</brief_summary>
	<brief_title>Functional Neurochemical Brain Changes Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Inclusion Criteria Depressed bipolar patient ( N=100 ; 1520 patients/year ) : 1 . Patients meet DSMIV criterion type I bipolar disorder , depress , determine structure interview bestestimate diagnostic procedures.138 2 . Patient experience maximum three document affective episode . 3 . Patient medication one week prior study enrollment . 4 . Patient Hamilton Depression Rating Scale ( HDRS ) total score ≥20 5 . Patient age 12 35 year . Exclusion criterion : All subject exclude participation follow reason : 1 . Any chemical use disorder within 3 month . 2 . Any history significant suicidality would place patient risk participate protocol . 3 . Current score ≥3 item 3 HDRS17 ( Suicide Item ) 4 . Any medical neurological disorder could influence fMRI result . 5 . A history mental retardation estimate IQ total score &lt; 85 . 6 . An MRI scan contraindicate subject reason . 7 . The patient live &gt; 100 mile University Cincinnati attend followup visit . 8 . Meets DSMIV criterion bipolar mixed episode</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>